Development and validation of a magnetic resonance imaging-based model for the prediction of distant metastasis before initial treatment of nasopharyngeal carcinoma: A retrospective cohort study

[1]  Robert M. Haralick,et al.  Textural Features for Image Classification , 1973, IEEE Trans. Syst. Man Cybern..

[2]  Mary M. Galloway,et al.  Texture analysis using gray level run lengths , 1974 .

[3]  James F. Greenleaf,et al.  Use of gray value distribution of run lengths for texture analysis , 1990, Pattern Recognit. Lett..

[4]  D. Rimm,et al.  X-Tile , 2004, Clinical Cancer Research.

[5]  E. Elkin,et al.  Decision Curve Analysis: A Novel Method for Evaluating Prediction Models , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

[6]  J. Zell,et al.  Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  Elena B. Elkin,et al.  Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers , 2008, BMC Medical Informatics Decis. Mak..

[8]  Jin-Ching Lin,et al.  Plasma EBV DNA Clearance Rate as a Novel Prognostic Marker for Metastatic/Recurrent Nasopharyngeal Carcinoma , 2010, Clinical Cancer Research.

[9]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[10]  X. An,et al.  Plasma Epstein‐Barr virus DNA level strongly predicts survival in metastatic/recurrent nasopharyngeal carcinoma treated with palliative chemotherapy , 2011, Cancer.

[11]  H. Adami,et al.  Eight-signature classifier for prediction of nasopharyngeal [corrected] carcinoma survival. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  V. Grégoire,et al.  Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  Ying Sun,et al.  Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. , 2012, The Lancet. Oncology.

[14]  Ying Sun,et al.  Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial. , 2012, The Lancet. Oncology.

[15]  C. Qian,et al.  A prognostic model predicts the risk of distant metastasis and death for patients with nasopharyngeal carcinoma based on pre-treatment serum C-reactive protein and N-classification. , 2013, European journal of cancer.

[16]  Benjamin Haibe-Kains,et al.  mRMRe: an R package for parallelized mRMR ensemble feature selection , 2013, Bioinform..

[17]  P. Lambin,et al.  CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  Wei Shi,et al.  Identification of a microRNA signature associated with risk of distant metastasis in nasopharyngeal carcinoma , 2014, Oncotarget.

[19]  I. El Naqa,et al.  A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities , 2015, Physics in medicine and biology.

[20]  Jun Ma,et al.  Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. , 2015, The Lancet. Oncology.

[21]  Jianji Pan,et al.  Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial , 2016, The Lancet.

[22]  Raymond H Mak,et al.  Radiomic phenotype features predict pathological response in non-small cell lung cancer. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  Erich P Huang,et al.  MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays. , 2016, Radiology.

[24]  M. Chua,et al.  Gemcitabine: a game changer in nasopharyngeal carcinoma , 2016, The Lancet.

[25]  H. Aerts.  The Potential of Radiomic-Based Phenotyping in Precision Medicine: A Review. , 2016, JAMA oncology.

[26]  Yanqi Huang,et al.  Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  Matthias Guckenberger,et al.  Computed Tomography Radiomics Predicts HPV Status and Local Tumor Control After Definitive Radiochemotherapy in Head and Neck Squamous Cell Carcinoma. , 2017, International journal of radiation oncology, biology, physics.

[28]  J. Ritz,et al.  Epstein‐Barr virus‐specific adoptive immunotherapy for recurrent, metastatic nasopharyngeal carcinoma , 2017, Cancer.

[29]  Lu Zhang,et al.  Advanced nasopharyngeal carcinoma: pre-treatment prediction of progression based on multi-parametric MRI radiomics , 2017, Oncotarget.

[30]  L. Cozzi,et al.  Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery , 2018, European Journal of Nuclear Medicine and Molecular Imaging.

[31]  D. Dong,et al.  Radiomics Features of Multiparametric MRI as Novel Prognostic Factors in Advanced Nasopharyngeal Carcinoma , 2017, Clinical Cancer Research.

[32]  S. Liang,et al.  Development and external validation of nomograms to predict the risk of skeletal metastasis at the time of diagnosis and skeletal metastasis-free survival in nasopharyngeal carcinoma , 2017, BMC Cancer.

[33]  John Quackenbush,et al.  Somatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer. , 2017, Cancer research.

[34]  Xinran Tang,et al.  HOPX hypermethylation promotes metastasis via activating SNAIL transcription in nasopharyngeal carcinoma , 2017, Nature Communications.

[35]  Andriy Fedorov,et al.  Computational Radiomics System to Decode the Radiographic Phenotype. , 2017, Cancer research.

[36]  Qianjin Feng,et al.  Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomics of T2-weighted fat-suppression and diffusion-weighted MRI , 2018, European Radiology.

[37]  P. Lambin,et al.  Radiomics: the bridge between medical imaging and personalized medicine , 2017, Nature Reviews Clinical Oncology.

[38]  Ying Sun,et al.  Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study. , 2018, The Lancet. Oncology.

[39]  D. Dong,et al.  A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy , 2018, Clinical Cancer Research.

[40]  Benjamin Haibe-Kains,et al.  Radiomic Biomarkers to Refine Risk Models for Distant Metastasis in HPV-related Oropharyngeal Carcinoma. , 2018, International journal of radiation oncology, biology, physics.

[41]  M. Huang,et al.  Development and Validation of an MRI-Based Radiomics Signature for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer , 2018, EBioMedicine.

[42]  Hyunjin Park,et al.  Radiomics Signature on Magnetic Resonance Imaging: Association with Disease-Free Survival in Patients with Invasive Breast Cancer , 2018, Clinical Cancer Research.

[43]  Ying Sun,et al.  Optimizing the induction chemotherapy regimen for patients with locoregionally advanced nasopharyngeal Carcinoma: A big-data intelligence platform-based analysis. , 2018, Oral oncology.